Interaction between p12CDK2AP1 and a novel unnamed protein product inhibits cell proliferation by regulating the cell

Lijun Liu1, Xiangming Yang, Qianwei Ni

  • 1Department of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.

Molecular Medicine Reports
|November 20, 2013
PubMed

Insights

Researchers identified a novel protein that interacts with human p12CDK2AP1 (cyclin-dependent kinase 2-associated protein 1). This interaction suppresses cell proliferation and may offer new cancer therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • p12CDK2AP1 (cyclin-dependent kinase 2-associated protein 1) is a protein that suppresses cell growth, differentiation, and angiogenesis in various carcinomas.
  • Its functions are primarily mediated through protein-protein interactions, highlighting the need to identify interacting partners to understand its role in cell cycle regulation and carcinogenesis.

Purpose of the Study:

  • To identify novel proteins that interact with human p12CDK2AP1.
  • To characterize the functional role of a newly identified interacting protein in cell cycle regulation and tumor growth.

Main Methods:

  • Yeast two-hybrid system for initial protein interaction screening.
  • Glutathione S-transferase pull-down and co-immunoprecipitation assays for in vitro interaction verification.
  • Quantitative PCR (qPCR), cell cycle analysis via flow cytometry, and in vivo tumor xenograft models in Balb/c nude mice.

Main Results:

  • A novel unnamed protein product (UPP, BC006130) was identified as a p12CDK2AP1-interacting protein.
  • UPP expression levels are regulated by the CDK2AP1 gene, and UPP overexpression shortens the G2/M phase of the cell cycle.
  • In vivo studies demonstrated that UPP gene transfection inhibits tumor cell proliferation.

Conclusions:

  • A novel p12CDK2AP1-interacting protein (UPP) was identified and characterized.
  • This novel protein may inhibit cell proliferation by mediating the cell cycle, expanding the understanding of p12CDK2AP1 mechanisms.
  • The identified protein represents a potential cancer therapeutic target.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K